Literature DB >> 26622661

Management of nasopharyngeal angiofibroma in a 72-year-old male through a sublabial and buccolabial incision approach: A case report and literature review.

Huan-Kang Zhang1, Jing-Jing Wang1, Zhuo-Fu Liu1, DE-Hui Wang1.   

Abstract

Nasopharyngeal angiofibroma (NA) primarily affects adolescent males. The incidence of NA in the elderly, however, is extremely low. The present study describes a 72-year-old male with NA that presented with typical symptoms and radiological findings. The location and extension of the tumor was too lateral and inferior to be effectively resected by an endoscopic approach. Therefore, a combination of endoscopic and open approaches was considered. The tumor was completely resected using an image-guided endoscopic-assisted sublabial and buccolabial incision approach. The post-operative histopathological and immunohistochemical analysis confirmed the diagnosis of NA. The present study demonstrated the occurrence of NA in the elderly, and highlighted the potential of an image-guided endoscopic-assisted sublabial and buccolabial incision approach for the treatment of NA in the elderly.

Entities:  

Keywords:  aged; histopathology; immunohistochemistry; nasopharyngeal angiofibroma

Year:  2015        PMID: 26622661      PMCID: PMC4533725          DOI: 10.3892/ol.2015.3410

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Nasopharyngeal angiofibroma in the juvenile.

Authors:  J Conley; W V Healey; S M Blaugrund; K H Erzin
Journal:  Surg Gynecol Obstet       Date:  1968-04

2.  Diagnosis and treatment of juvenile nasopharyngeal angiofibroma.

Authors:  J Paris; B Guelfucci; G Moulin; M Zanaret; J M Triglia
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-03       Impact factor: 2.503

3.  Use of image guidance in endoscopic endonasal surgeries: a 5-year experience.

Authors:  M Farhadi; M Jalessi; G Sharifi; S Khamesi; E Bahrami; M R Hammami; A H Behzadi
Journal:  B-ENT       Date:  2011       Impact factor: 0.082

4.  Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.

Authors:  Marc P Pusztaszeri; Walter Seelentag; Fred T Bosman
Journal:  J Histochem Cytochem       Date:  2005-10-18       Impact factor: 2.479

5.  Analysis of risk factors associated with recurrence of nasopharyngeal angiofibroma.

Authors:  Xi-Cai Sun; De-Hui Wang; Hua-Peng Yu; Feng Wang; Wei Wang; Jack J Jiang
Journal:  J Otolaryngol Head Neck Surg       Date:  2010-02

6.  Endoscopic assisted antral window approach for type III nasopharyngeal angiofibroma with infratemporal fossa extension.

Authors:  Mohamed A Khalifa; Sameh M Ragab
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-10-25       Impact factor: 1.675

7.  Anti-vimentin staining in muscle pathology.

Authors:  A Bornemann; H Schmalbruch
Journal:  Neuropathol Appl Neurobiol       Date:  1993-10       Impact factor: 8.090

Review 8.  Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases.

Authors:  Zain Boghani; Qasim Husain; Vivek V Kanumuri; Mohemmed N Khan; Saurin Sangvhi; James K Liu; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2013-03-11       Impact factor: 3.325

9.  Juvenile nasopharyngeal angiofibroma in a tertiary centre: ten-year experience.

Authors:  I P Tang; S Shashinder; G Gopala Krishnan; P Narayanan
Journal:  Singapore Med J       Date:  2009-03       Impact factor: 1.858

10.  Surgical management of juvenile nasopharyngeal angiofibroma: analysis of 162 cases from 1995 to 2012.

Authors:  Yang Huang; Zhuofu Liu; Jingjing Wang; Xicai Sun; Lei Yang; Dehui Wang
Journal:  Laryngoscope       Date:  2014-05-27       Impact factor: 3.325

View more
  1 in total

1.  Nasopharyngeal Angiofibroma: A Forgotten Entity in Older Patients.

Authors:  Vanessa C Stubbs; Lauren E Miller; Arjun K Parasher; Jordan T Glicksman; Nithin D Adappa; James Palmer
Journal:  Clin Med Insights Case Rep       Date:  2019-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.